25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SINTX Technologies Inc
Buy, Hold or Sell?

Let's analyze Sintx together

I guess you are interested in SINTX Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SINTX Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about SINTX Technologies Inc

I send you an email if I find something interesting about SINTX Technologies Inc.

1. Quick Overview

1.1. Quick analysis of Sintx (30 sec.)










1.2. What can you expect buying and holding a share of Sintx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$6.22
Expected worth in 1 year
$9.90
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$3.68
Return On Investment
106.0%

For what price can you sell your share?

Current Price per Share
$3.47
Expected price per share
$2.01 - $8.5961
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sintx (5 min.)




Live pricePrice per Share (EOD)
$3.47
Intrinsic Value Per Share
$-65.97 - $106.79
Total Value Per Share
$-59.75 - $113.01

2.2. Growth of Sintx (5 min.)




Is Sintx growing?

Current yearPrevious yearGrowGrow %
How rich?$5.5m$11.5m-$3.2m-39.3%

How much money is Sintx making?

Current yearPrevious yearGrowGrow %
Making money-$2.9m-$2.7m-$141.5k-4.9%
Net Profit Margin-355.9%-920.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Sintx (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#249 / 320

Most Revenue
#266 / 320

Most Profit
#193 / 320

Most Efficient
#272 / 320
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sintx?

Welcome investor! Sintx's management wants to use your money to grow the business. In return you get a share of Sintx.

First you should know what it really means to hold a share of Sintx. And how you can make/lose money.

Speculation

The Price per Share of Sintx is $3.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sintx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sintx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $6.22. Based on the TTM, the Book Value Change Per Share is $0.92 per quarter. Based on the YOY, the Book Value Change Per Share is $-2.51 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sintx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-6.95-200.4%-3.55-102.3%-3.19-91.8%-3.65-105.2%-4.21-121.4%
Usd Book Value Change Per Share-5.62-161.9%0.9226.5%-2.51-72.5%-0.09-2.7%-0.24-7.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.3%0.226.2%
Usd Total Gains Per Share-5.62-161.9%0.9226.5%-2.51-72.5%-0.08-2.4%-0.03-0.8%
Usd Price Per Share3.26-2.12-3.44-1.83-3.43-
Price to Earnings Ratio-0.12--0.14--1.24--0.34--0.33-
Price-to-Total Gains Ratio-0.58--0.96--1.64--0.74--0.71-
Price to Book Ratio0.52-0.24-0.56-0.20-0.25-
Price-to-Total Gains Ratio-0.58--0.96--1.64--0.74--0.71-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.47
Number of shares288
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.92-0.09
Usd Total Gains Per Share0.92-0.08
Gains per Quarter (288 shares)264.92-23.57
Gains per Year (288 shares)1,059.69-94.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101060105012-106-104
202119211024-213-198
303179317036-319-292
404239423048-426-386
505298529061-532-480
606358635073-638-574
707418741085-745-668
808478847097-851-762
9095379530109-957-856
1001059710590121-1064-950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%2.047.02.03.9%
Book Value Change Per Share2.02.00.050.0%2.010.00.016.7%5.015.00.025.0%13.027.00.032.5%16.033.02.031.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%2.00.038.05.0%2.00.049.03.9%
Total Gains per Share2.02.00.050.0%2.010.00.016.7%5.015.00.025.0%14.026.00.035.0%17.032.02.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of SINTX Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---5.6180.920-711%-2.515-55%-0.092-98%-0.245-96%
Book Value Per Share--6.22010.769-42%5.145+21%17.027-63%14.808-58%
Current Ratio--3.0442.182+40%2.150+42%4.295-29%2.857+7%
Debt To Asset Ratio--0.5060.448+13%0.381+33%0.311+63%0.438+16%
Debt To Equity Ratio--1.0250.819+25%0.755+36%0.517+98%1.236-17%
Dividend Per Share----0%-0%0.011-100%0.215-100%
Enterprise Value--2017272.980-273178.017+114%6960576.395-71%8024382.855-75%1652752.256+22%
Eps---6.953-3.548-49%-3.187-54%-3.652-47%-4.213-39%
Ev To Ebitda Ratio---0.0790.268-129%-0.569+623%-0.865+999%-0.233+196%
Ev To Sales Ratio--0.631-0.092+115%6.467-90%16.615-96%8.318-92%
Free Cash Flow Per Share---2.876-3.624+26%-1.741-39%-3.398+18%-3.091+7%
Free Cash Flow To Equity Per Share--0.309-0.603+295%0.799-61%0.104+197%-0.650+311%
Gross Profit Margin--1.0141.130-10%1.035-2%1.096-8%1.282-21%
Intrinsic Value_10Y_max--106.793--------
Intrinsic Value_10Y_min---65.966--------
Intrinsic Value_1Y_max---9.039--------
Intrinsic Value_1Y_min---11.654--------
Intrinsic Value_3Y_max---12.113--------
Intrinsic Value_3Y_min---30.854--------
Intrinsic Value_5Y_max--2.950--------
Intrinsic Value_5Y_min---45.347--------
Market Cap2593106.710-13%2925272.9801708571.983+71%5077076.395-42%1893532.855+54%2824777.256+4%
Net Profit Margin---7.809-3.559-54%-9.205+18%-12.974+66%-7.621-2%
Operating Margin----1.6050%-11.7630%-13.8540%-8.5230%
Operating Ratio--8.7575.506+59%12.596-30%16.209-46%10.255-15%
Pb Ratio0.558+6%0.5240.241+117%0.560-6%0.195+168%0.251+109%
Pe Ratio-0.125-6%-0.117-0.141+21%-1.241+958%-0.339+189%-0.327+179%
Price Per Share3.470+6%3.2602.123+54%3.443-5%1.831+78%3.429-5%
Price To Free Cash Flow Ratio-0.302-6%-0.283-0.164-42%-0.412+45%-0.169-40%-0.357+26%
Price To Total Gains Ratio-0.618-6%-0.580-0.957+65%-1.639+182%-0.737+27%-0.709+22%
Quick Ratio--2.4781.761+41%1.889+31%4.001-38%2.524-2%
Return On Assets---0.552-0.224-59%-0.184-67%-0.138-75%-0.138-75%
Return On Equity---1.118-0.430-62%-0.441-61%-0.251-78%-0.328-71%
Total Gains Per Share---5.6180.920-711%-2.515-55%-0.082-99%-0.029-99%
Usd Book Value--5581000.0008281250.000-33%11537500.000-52%14309050.000-61%11858650.000-53%
Usd Book Value Change Per Share---5.6180.920-711%-2.515-55%-0.092-98%-0.245-96%
Usd Book Value Per Share--6.22010.769-42%5.145+21%17.027-63%14.808-58%
Usd Dividend Per Share----0%-0%0.011-100%0.215-100%
Usd Eps---6.953-3.548-49%-3.187-54%-3.652-47%-4.213-39%
Usd Free Cash Flow---2581000.000-2816000.000+9%-3455500.000+34%-2991850.000+16%-2536300.000-2%
Usd Free Cash Flow Per Share---2.876-3.624+26%-1.741-39%-3.398+18%-3.091+7%
Usd Free Cash Flow To Equity Per Share--0.309-0.603+295%0.799-61%0.104+197%-0.650+311%
Usd Market Cap2593106.710-13%2925272.9801708571.983+71%5077076.395-42%1893532.855+54%2824777.256+4%
Usd Price Per Share3.470+6%3.2602.123+54%3.443-5%1.831+78%3.429-5%
Usd Profit---6239000.000-2912500.000-53%-2771000.000-56%-2361800.000-62%-3006700.000-52%
Usd Revenue--799000.000811750.000-2%350000.000+128%322600.000+148%1613175.000-50%
Usd Total Gains Per Share---5.6180.920-711%-2.515-55%-0.082-99%-0.029-99%
 EOD+3 -5MRQTTM+14 -22YOY+12 -245Y+14 -2410Y+13 -25

3.3 Fundamental Score

Let's check the fundamental score of SINTX Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.125
Price to Book Ratio (EOD)Between0-10.558
Net Profit Margin (MRQ)Greater than0-7.809
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.478
Current Ratio (MRQ)Greater than13.044
Debt to Asset Ratio (MRQ)Less than10.506
Debt to Equity Ratio (MRQ)Less than11.025
Return on Equity (MRQ)Greater than0.15-1.118
Return on Assets (MRQ)Greater than0.05-0.552
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of SINTX Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.589
Ma 20Greater thanMa 503.484
Ma 50Greater thanMa 1003.287
Ma 100Greater thanMa 2003.764
OpenGreater thanClose3.890
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About SINTX Technologies Inc

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Fundamental data was last updated by Penke on 2024-11-16 02:01:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sintx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sintx to the Medical Devices industry mean.
  • A Net Profit Margin of -780.9% means that $-7.81 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SINTX Technologies Inc:

  • The MRQ is -780.9%. The company is making a huge loss. -2
  • The TTM is -355.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-780.9%TTM-355.9%-424.9%
TTM-355.9%YOY-920.5%+564.6%
TTM-355.9%5Y-1,297.4%+941.5%
5Y-1,297.4%10Y-762.1%-535.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-780.9%-6.4%-774.5%
TTM-355.9%-15.2%-340.7%
YOY-920.5%-15.4%-905.1%
5Y-1,297.4%-18.1%-1,279.3%
10Y-762.1%-22.9%-739.2%
4.3.1.2. Return on Assets

Shows how efficient Sintx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sintx to the Medical Devices industry mean.
  • -55.2% Return on Assets means that Sintx generated $-0.55 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SINTX Technologies Inc:

  • The MRQ is -55.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-55.2%TTM-22.4%-32.8%
TTM-22.4%YOY-18.4%-4.0%
TTM-22.4%5Y-13.8%-8.6%
5Y-13.8%10Y-13.8%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.2%-2.1%-53.1%
TTM-22.4%-3.2%-19.2%
YOY-18.4%-4.0%-14.4%
5Y-13.8%-3.1%-10.7%
10Y-13.8%-4.1%-9.7%
4.3.1.3. Return on Equity

Shows how efficient Sintx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sintx to the Medical Devices industry mean.
  • -111.8% Return on Equity means Sintx generated $-1.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SINTX Technologies Inc:

  • The MRQ is -111.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -43.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-111.8%TTM-43.0%-68.8%
TTM-43.0%YOY-44.1%+1.1%
TTM-43.0%5Y-25.1%-17.9%
5Y-25.1%10Y-32.8%+7.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-111.8%-2.4%-109.4%
TTM-43.0%-3.9%-39.1%
YOY-44.1%-4.5%-39.6%
5Y-25.1%-4.3%-20.8%
10Y-32.8%-5.6%-27.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of SINTX Technologies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sintx is operating .

  • Measures how much profit Sintx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sintx to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SINTX Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-160.5%+160.5%
TTM-160.5%YOY-1,176.3%+1,015.8%
TTM-160.5%5Y-1,385.4%+1,224.9%
5Y-1,385.4%10Y-852.3%-533.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.9%+12.9%
TTM-160.5%-18.2%-142.3%
YOY-1,176.3%-13.9%-1,162.4%
5Y-1,385.4%-16.3%-1,369.1%
10Y-852.3%-22.1%-830.2%
4.3.2.2. Operating Ratio

Measures how efficient Sintx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 8.76 means that the operating costs are $8.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of SINTX Technologies Inc:

  • The MRQ is 8.757. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.506. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ8.757TTM5.506+3.251
TTM5.506YOY12.596-7.090
TTM5.5065Y16.209-10.703
5Y16.20910Y10.255+5.954
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ8.7571.254+7.503
TTM5.5061.324+4.182
YOY12.5961.326+11.270
5Y16.2091.373+14.836
10Y10.2551.314+8.941
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of SINTX Technologies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sintx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.04 means the company has $3.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of SINTX Technologies Inc:

  • The MRQ is 3.044. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.182. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.044TTM2.182+0.863
TTM2.182YOY2.150+0.031
TTM2.1825Y4.295-2.113
5Y4.29510Y2.857+1.438
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0442.550+0.494
TTM2.1822.691-0.509
YOY2.1502.922-0.772
5Y4.2953.415+0.880
10Y2.8573.527-0.670
4.4.3.2. Quick Ratio

Measures if Sintx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sintx to the Medical Devices industry mean.
  • A Quick Ratio of 2.48 means the company can pay off $2.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SINTX Technologies Inc:

  • The MRQ is 2.478. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.761. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.478TTM1.761+0.717
TTM1.761YOY1.889-0.128
TTM1.7615Y4.001-2.240
5Y4.00110Y2.524+1.477
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4781.455+1.023
TTM1.7611.674+0.087
YOY1.8891.875+0.014
5Y4.0012.330+1.671
10Y2.5242.555-0.031
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of SINTX Technologies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sintx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sintx to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.51 means that Sintx assets are financed with 50.6% credit (debt) and the remaining percentage (100% - 50.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SINTX Technologies Inc:

  • The MRQ is 0.506. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.448. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.506TTM0.448+0.058
TTM0.448YOY0.381+0.067
TTM0.4485Y0.311+0.137
5Y0.31110Y0.438-0.126
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5060.407+0.099
TTM0.4480.397+0.051
YOY0.3810.360+0.021
5Y0.3110.433-0.122
10Y0.4380.457-0.019
4.5.4.2. Debt to Equity Ratio

Measures if Sintx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sintx to the Medical Devices industry mean.
  • A Debt to Equity ratio of 102.5% means that company has $1.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SINTX Technologies Inc:

  • The MRQ is 1.025. The company is able to pay all its debts with equity. +1
  • The TTM is 0.819. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.025TTM0.819+0.206
TTM0.819YOY0.755+0.064
TTM0.8195Y0.517+0.302
5Y0.51710Y1.236-0.719
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0250.552+0.473
TTM0.8190.596+0.223
YOY0.7550.525+0.230
5Y0.5170.630-0.113
10Y1.2360.711+0.525
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sintx generates.

  • Above 15 is considered overpriced but always compare Sintx to the Medical Devices industry mean.
  • A PE ratio of -0.12 means the investor is paying $-0.12 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SINTX Technologies Inc:

  • The EOD is -0.125. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.117. Based on the earnings, the company is expensive. -2
  • The TTM is -0.141. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.125MRQ-0.117-0.008
MRQ-0.117TTM-0.141+0.024
TTM-0.141YOY-1.241+1.099
TTM-0.1415Y-0.339+0.198
5Y-0.33910Y-0.327-0.012
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.125-1.133+1.008
MRQ-0.117-1.442+1.325
TTM-0.141-2.000+1.859
YOY-1.241-2.111+0.870
5Y-0.339-1.922+1.583
10Y-0.327-2.040+1.713
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SINTX Technologies Inc:

  • The EOD is -0.302. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.283. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.164. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.302MRQ-0.283-0.018
MRQ-0.283TTM-0.164-0.119
TTM-0.164YOY-0.412+0.248
TTM-0.1645Y-0.169+0.005
5Y-0.16910Y-0.357+0.188
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.302-1.367+1.065
MRQ-0.283-1.829+1.546
TTM-0.164-2.190+2.026
YOY-0.412-5.489+5.077
5Y-0.169-3.987+3.818
10Y-0.357-4.828+4.471
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sintx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.52 means the investor is paying $0.52 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of SINTX Technologies Inc:

  • The EOD is 0.558. Based on the equity, the company is cheap. +2
  • The MRQ is 0.524. Based on the equity, the company is cheap. +2
  • The TTM is 0.241. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.558MRQ0.524+0.034
MRQ0.524TTM0.241+0.283
TTM0.241YOY0.560-0.319
TTM0.2415Y0.195+0.046
5Y0.19510Y0.251-0.055
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.5582.190-1.632
MRQ0.5242.142-1.618
TTM0.2412.358-2.117
YOY0.5603.005-2.445
5Y0.1954.156-3.961
10Y0.2514.646-4.395
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of SINTX Technologies Inc.

4.8.1. Institutions holding SINTX Technologies Inc

Institutions are holding 1.713% of the shares of SINTX Technologies Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30UBS Group AG0.57210427542750
2024-06-30Tower Research Capital LLC0.41360.0003309130446476.5957
2024-09-30SignatureFD, LLC0.15320.0001114500
2024-06-30Citigroup Inc0.13960104310430
2024-06-30Headlands Technologies LLC0.03430.00012562560
2024-06-30Morgan Stanley - Brokerage Accounts0.003502615136.3636
2024-06-30Qube Research & Technologies0.0025019190
2024-06-30Bank of America Corp0.00080660
2024-06-30Advisor Group Holdings, Inc.0.00030220
2024-06-30HARBOUR INVESTMENTS, INC.0.00010110
2024-09-30Hanson Mcclain Inc0.00010100
2024-06-30Cornerstone Planning Group LLC0.00010110
2024-06-30State Street Corp000-86-100
2024-06-30Wells Fargo & Co00000
2024-06-30KESTRA PRIVATE WEALTH SERVICES, LLC000-50-100
2024-06-30Heritage Wealth Advisors, LLC000-3-100
2024-06-30FMR Inc00000
2024-06-30Citadel Advisors Llc000-56-100
2024-06-30Vanguard Group Inc000-217-100
2024-06-30Geode Capital Management, LLC000-109-100
Total 1.32020.00059866+8141+82.5%

4.9.2. Funds holding SINTX Technologies Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Fidelity Extended Market Index0.45930343200
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr0.0292021800
2024-09-30BNYM Mellon SL Market Completion UC10.00030200
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.00030200
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.00030200
2024-09-30NT Ext Equity Mkt Idx Fd - L0.00030200
2024-10-31State St US Extended Mkt Indx NL Cl C0.00010100
2024-09-30Northern Trust Wilshire 50000.00010100
2024-03-14iShares Core S&P Total US Stock Mkt ETF00110
Total 0.489903661+1+0.0%

5.3. Insider Transactions

Insiders are holding 3.014% of the shares of SINTX Technologies Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets11,303
Total Liabilities5,722
Total Stockholder Equity5,581
 As reported
Total Liabilities 5,722
Total Stockholder Equity+ 5,581
Total Assets = 11,303

Assets

Total Assets11,303
Total Current Assets6,332
Long-term Assets4,971
Total Current Assets
Cash And Cash Equivalents 4,814
Net Receivables 340
Inventory 463
Other Current Assets 715
Total Current Assets  (as reported)6,332
Total Current Assets  (calculated)6,332
+/-0
Long-term Assets
Property Plant Equipment 4,316
Intangible Assets 17
Long-term Assets Other 638
Long-term Assets  (as reported)4,971
Long-term Assets  (calculated)4,971
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,080
Long-term Liabilities3,642
Total Stockholder Equity5,581
Total Current Liabilities
Short-term Debt 469
Accounts payable 153
Other Current Liabilities 1,458
Total Current Liabilities  (as reported)2,080
Total Current Liabilities  (calculated)2,080
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)3,642
Long-term Liabilities  (calculated)0
+/- 3,642
Total Stockholder Equity
Common Stock13
Retained Earnings -280,043
Other Stockholders Equity 285,611
Total Stockholder Equity (as reported)5,581
Total Stockholder Equity (calculated)5,581
+/-0
Other
Cash and Short Term Investments 4,814
Common Stock Shares Outstanding 897
Liabilities and Stockholders Equity 11,303
Net Debt -703
Net Working Capital 4,252
Short Long Term Debt Total 4,111



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302011-12-312007-03-312006-12-312005-12-31
> Total Assets 
7,988
19,861
17,208
61,220
0
33,455
0
28,872
35,569
34,327
43,848
43,330
42,349
47,583
43,658
39,971
37,193
36,454
31,081
27,505
31,435
26,261
26,081
26,261
26,081
14,641
14,817
22,607
14,397
11,515
10,257
11,277
10,598
9,147
15,363
24,585
32,633
30,447
28,685
26,416
24,868
21,840
18,883
17,494
14,563
15,773
22,651
19,098
15,512
15,365
17,561
15,296
11,303
11,30315,29617,56115,36515,51219,09822,65115,77314,56317,49418,88321,84024,86826,41628,68530,44732,63324,58515,3639,14710,59811,27710,25711,51514,39722,60714,81714,64126,08126,26126,08126,26131,43527,50531,08136,45437,19339,97143,65847,58342,34943,33043,84834,32735,56928,872033,455061,22017,20819,8617,988
   > Total Current Assets 
0
0
0
0
0
19,043
5,421
14,825
21,255
19,910
29,463
28,745
27,790
33,682
30,111
26,826
24,515
24,097
18,988
15,780
20,109
15,987
10,263
15,987
10,263
3,210
3,590
11,542
10,956
7,017
5,572
5,083
4,865
4,063
10,990
20,844
29,587
27,590
25,760
23,209
18,146
15,028
11,989
9,228
6,048
7,209
14,291
11,100
7,912
5,532
7,514
5,861
6,332
6,3325,8617,5145,5327,91211,10014,2917,2096,0489,22811,98915,02818,14623,20925,76027,59029,58720,84410,9904,0634,8655,0835,5727,01710,95611,5423,5903,21010,26315,98710,26315,98720,10915,78018,98824,09724,51526,82630,11133,68227,79028,74529,46319,91021,25514,8255,42119,04300000
       Cash And Cash Equivalents 
0
0
0
3,331
0
2,741
-5,421
1,135
7,562
2,279
13,257
11,550
10,360
18,247
14,882
12,394
11,268
11,485
7,943
5,155
10,613
6,915
6,944
6,915
6,944
539
409
8,835
6,793
5,447
4,164
3,192
2,926
1,787
8,224
18,125
27,050
25,351
23,471
22,175
17,183
14,273
10,863
7,747
4,779
6,245
12,626
9,328
6,219
3,340
5,762
4,557
4,814
4,8144,5575,7623,3406,2199,32812,6266,2454,7797,74710,86314,27317,18322,17523,47125,35127,05018,1258,2241,7872,9263,1924,1645,4476,7938,8354095396,9446,9156,9446,91510,6135,1557,94311,48511,26812,39414,88218,24710,36011,55013,2572,2797,5621,135-5,4212,74103,331000
       Short-term Investments 
0
0
0
7,809
0
2,680
10,842
1,619
298
392
434
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000004343922981,61910,8422,68007,809000
       Net Receivables 
0
0
0
0
0
4,016
0
2,891
2,344
2,817
2,566
3,060
3,166
2,513
2,568
2,509
2,376
2,660
1,848
1,950
1,270
1,620
1,702
1,620
1,702
1,240
1,571
1,204
1,201
1,347
1,161
1,572
1,716
1,860
2,088
2,179
2,238
1,897
1,383
29
182
102
106
268
230
328
467
385
259
685
483
434
340
340434483685259385467328230268106102182291,3831,8972,2382,1792,0881,8601,7161,5721,1611,3471,2011,2041,5711,2401,7021,6201,7021,6201,2701,9501,8482,6602,3762,5092,5682,5133,1663,0602,5662,8172,3442,89104,01600000
       Inventory 
0
0
0
11,397
0
8,826
0
8,625
9,210
10,084
11,628
12,671
12,632
11,675
11,197
10,611
9,700
9,131
8,492
8,144
7,851
7,213
1,425
7,213
1,425
1,241
1,231
1,237
817
52
69
85
86
106
207
137
74
99
108
354
399
303
299
346
326
284
388
695
848
888
707
445
463
4634457078888486953882843263462993033993541089974137207106868569528171,2371,2311,2411,4257,2131,4257,2137,8518,1448,4929,1319,70010,61111,19711,67512,63212,67111,62810,0849,2108,62508,826011,397000
   > Long-term Assets 
0
0
0
0
0
14,412
-5,421
14,047
14,314
14,417
14,385
14,585
14,559
13,901
13,547
13,145
12,678
12,357
12,093
11,725
11,326
10,274
15,818
10,274
15,818
11,431
11,227
11,065
3,441
4,498
4,685
6,194
5,733
5,084
4,373
3,741
3,046
2,857
2,925
3,207
6,722
6,812
6,894
8,266
8,515
8,564
8,360
7,998
7,600
9,833
10,047
9,435
4,971
4,9719,43510,0479,8337,6007,9988,3608,5648,5158,2666,8946,8126,7223,2072,9252,8573,0463,7414,3735,0845,7336,1944,6854,4983,44111,06511,22711,43115,81810,27415,81810,27411,32611,72512,09312,35712,67813,14513,54713,90114,55914,58514,38514,41714,31414,047-5,42114,41200000
       Property Plant Equipment 
1,370
4,057
4,535
4,979
0
3,023
0
2,911
3,303
3,531
3,624
3,949
4,048
3,515
3,286
3,009
2,668
2,472
2,333
2,090
1,816
889
6,567
889
1,019
1,446
1,332
1,212
150
124
597
2,622
2,647
2,531
2,432
2,367
2,318
2,397
2,448
2,738
6,327
6,410
6,440
7,728
7,984
8,000
8,013
7,706
7,278
8,920
9,000
8,606
4,316
4,3168,6069,0008,9207,2787,7068,0138,0007,9847,7286,4406,4106,3272,7382,4482,3972,3182,3672,4322,5312,6472,6225971241501,2121,3321,4461,0198896,5678891,8162,0902,3332,4722,6683,0093,2863,5154,0483,9493,6243,5313,3032,91103,02304,9794,5354,0571,370
       Goodwill 
0
0
0
6,163
0
6,163
0
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
6,163
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000006,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,16306,16306,163000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,669
3,343
2,897
2,383
1,944
1,361
778
194
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001947781,3611,9442,3832,8973,3433,66900000000000000000000000000000
       Intangible Assets 
0
0
0
28,517
0
5,189
0
4,939
4,814
4,688
4,563
4,438
4,313
4,188
4,063
3,938
3,812
3,687
3,562
3,437
3,312
3,187
3,053
3,187
3,053
2,651
2,567
2,432
2,297
46
45
44
43
41
40
39
37
36
35
34
33
31
30
29
27
26
25
24
22
21
20
19
17
1719202122242526272930313334353637394041434445462,2972,4322,5672,6513,0533,1873,0533,1873,3123,4373,5623,6873,8123,9384,0634,1884,3134,4384,5634,6884,8144,93905,189028,517000
       Long-term Assets Other 
0
0
0
0
0
38
-5,421
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
5,583
35
5,583
1,171
1,165
1,258
994
4,328
4,043
3,528
3,043
2,512
1,901
1,335
691
424
442
435
362
371
424
509
504
538
322
268
300
892
1,027
810
638
6388101,0278923002683225385045094243713624354424246911,3351,9012,5123,0433,5284,0434,3289941,2581,1651,1715,583355,583353535353535353535353535353535-5,4213800000
> Total Liabilities 
0
0
0
57,998
0
181,737
0
180,535
27,557
187,388
23,386
28,468
30,392
40,676
40,477
31,810
38,910
22,222
20,148
17,752
14,110
11,888
9,991
11,888
9,991
9,199
8,831
11,298
6,307
3,116
3,487
4,837
4,570
3,945
4,155
5,389
5,097
4,643
5,087
4,937
5,628
4,112
4,432
5,445
5,148
10,069
6,706
5,286
4,823
6,593
7,635
6,450
5,722
5,7226,4507,6356,5934,8235,2866,70610,0695,1485,4454,4324,1125,6284,9375,0874,6435,0975,3894,1553,9454,5704,8373,4873,1166,30711,2988,8319,1999,99111,8889,99111,88814,11017,75220,14822,22238,91031,81040,47740,67630,39228,46823,386187,38827,557180,5350181,737057,998000
   > Total Current Liabilities 
396
1,597
858
14,944
0
24,214
0
22,762
22,962
25,013
22,371
23,850
23,963
22,994
23,491
23,790
23,999
21,021
18,970
16,129
13,018
10,853
8,905
10,853
8,905
8,271
7,948
10,417
5,456
2,380
2,872
2,172
2,053
2,066
2,363
3,466
3,359
2,879
3,205
3,196
3,153
2,214
2,669
2,977
2,872
8,078
5,126
3,926
3,778
2,906
4,088
3,021
2,080
2,0803,0214,0882,9063,7783,9265,1268,0782,8722,9772,6692,2143,1533,1963,2052,8793,3593,4662,3632,0662,0532,1722,8722,3805,45610,4177,9488,2718,90510,8538,90510,85313,01816,12918,97021,02123,99923,79023,49122,99423,96323,85022,37125,01322,96222,762024,214014,9448581,597396
       Short-term Debt 
0
0
0
0
0
20,466
0
19,180
17,917
17,925
16,132
18,900
18,984
19,070
19,157
19,766
19,973
16,957
14,785
10,681
8,451
7,012
5,482
7,012
5,482
2,961
4,513
2,479
1,566
1,062
715
587
481
366
379
563
631
512
414
451
537
500
1,037
853
888
898
867
863
869
1,070
751
735
469
4697357511,0708698638678988888531,0375005374514145126315633793664815877151,0621,5662,4794,5132,9615,4827,0125,4827,0128,45110,68114,78516,95719,97319,76619,15719,07018,98418,90016,13217,92517,91719,180020,46600000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
19,070
0
0
0
16,365
0
0
0
7,012
0
0
4,614
605
2,095
0
0
0
715
0
6
6
7
180
238
109
1
28
59
0
524
148
168
160
117
94
72
46
233
241
0
024123346729411716016814852405928110923818076607150002,0956054,614007,01200016,36500019,0700000000000000
       Accounts payable 
207
975
242
1,389
0
2,142
0
1,515
3,089
3,377
2,275
2,584
1,326
778
1,217
831
912
643
982
1,960
693
3,841
3,423
658
587
1,732
2,025
910
703
301
254
295
166
191
173
96
157
194
397
154
169
217
490
372
289
434
486
502
481
636
448
331
153
153331448636481502486434289372490217169154397194157961731911662952543017039102,0251,7325876583,4233,8416931,9609826439128311,2177781,3262,5842,2753,3773,0891,51502,14201,389242975207
       Other Current Liabilities 
189
245
197
8,697
0
22,072
0
2,060
19,874
21,636
3,964
2,366
3,653
3,146
3,117
3,193
3,114
3,421
3,203
19
3,893
6,320
5,015
3,183
2,836
896
300
6,061
4,753
2,079
1,106
477
340
243
849
1,526
1,625
1,264
1,308
1,322
842
347
1,142
1,752
1,695
6,746
3,773
1,054
680
1,200
2,889
1,955
1,458
1,4581,9552,8891,2006801,0543,7736,7461,6951,7521,1423478421,3221,3081,2641,6251,5268492433404771,1062,0794,7536,0613008962,8363,1835,0156,3203,893193,2033,4213,1143,1933,1173,1463,6532,3663,96421,63619,8742,060022,07208,697197245189
   > Long-term Liabilities 
0
0
0
0
0
157,523
0
157,773
4,595
162,375
1,015
4,618
6,429
17,682
16,986
8,020
14,911
1,201
1,178
1,623
1,092
1,036
1,086
1,035
1,086
928
883
881
851
736
615
2,665
2,517
1,879
1,792
1,923
1,738
1,764
1,882
1,741
2,475
1,898
1,763
2,468
2,276
1,991
1,580
1,360
1,045
3,687
3,547
3,429
3,642
3,6423,4293,5473,6871,0451,3601,5801,9912,2762,4681,7631,8982,4751,7411,8821,7641,7381,9231,7921,8792,5172,6656157368518818839281,0861,0351,0861,0361,0921,6231,1781,20114,9118,02016,98617,6826,4294,6181,015162,3754,595157,7730157,52300000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
1,216
3,718
3,061
3,110
2,779
0
0
0
469
0
0
0
0
0
0
0
0
0
0
0
0
15
12
10
241
158
287
513
482
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000004825132871582411012150000000000004690002,7793,1103,0613,7181,21600000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-20,466
0
-19,180
-17,917
-17,925
-16,132
-18,900
-18,984
-19,070
-19,157
-19,766
-19,973
-16,957
-14,785
-10,681
-8,451
-7,012
-5,482
-7,012
-5,482
-2,961
-4,513
-2,479
-1,566
-1,062
0
2,050
1,953
1,861
1,775
1,502
1,342
1,368
1,368
1,231
1,966
1,898
1,239
1,820
1,643
1,461
1,430
1,253
973
3,129
3,314
3,188
-469
-4693,1883,3143,1299731,2531,4301,4611,6431,8201,2391,8981,9661,2311,3681,3681,3421,5021,7751,8611,9532,0500-1,062-1,566-2,479-4,513-2,961-5,482-7,012-5,482-7,012-8,451-10,681-14,785-16,957-19,973-19,766-19,157-19,070-18,984-18,900-16,132-17,925-17,917-19,1800-20,46600000
       Warrants
0
0
0
0
0
0
0
0
0
0
319
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000003190000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
134
134
134
134
134
177
174
171
169
166
196
189
283
280
278
288
287
141
141
232
115
2,163
2,050
1,867
1,782
1,682
1,580
1,477
1,369
1,259
0
0
0
393
393
2
0
0
0
0
0
0
0
000000023933930001,2591,3691,4771,5801,6821,7821,8672,0502,1631152321411412872882782802831891961661691711741771341341341341340000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
562
3,268
2,577
14,487
13,742
5,064
14,737
432
1,009
950
896
847
803
767
721
640
596
740
710
504
500
502
452
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000004525025005047107405966407217678038478969501,00943214,7375,06413,74214,4872,5773,2685620000000000
> Total Stockholder Equity
0
0
0
3,222
0
-148,282
5,717
-151,663
8,012
-153,061
20,462
14,862
11,957
6,907
3,181
8,161
-1,717
14,232
10,933
9,753
17,325
11,235
13,911
14,373
16,090
5,442
5,986
11,309
8,090
8,399
6,770
6,440
6,028
5,202
11,208
19,196
27,536
25,804
23,598
21,479
19,240
17,728
14,451
12,049
9,415
5,704
15,945
13,812
10,689
8,772
9,926
8,846
5,581
5,5818,8469,9268,77210,68913,81215,9455,7049,41512,04914,45117,72819,24021,47923,59825,80427,53619,19611,2085,2026,0286,4406,7708,3998,09011,3095,9865,44216,09014,37313,91111,23517,3259,75310,93314,232-1,7178,1613,1816,90711,95714,86220,462-153,0618,012-151,6635,717-148,28203,222000
   Retained Earnings -280,043-273,804-271,600-270,714-268,393-265,203-262,748-262,455-258,498-255,774-253,262-249,883-248,282-245,939-243,740-241,107-239,375-236,937-232,909-234,078-233,086-231,641-230,910-229,281-229,587-226,340-224,028-220,629-215,285-213,135-215,285-213,135-209,327-204,989-199,925-196,537-194,072-183,940-177,886-172,505-162,807-157,875-144,636-139,923-140,585-138,0060-131,63700000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
2
-148,283
0
-14,451
-14,220
-43,848
-43,330
-42,349
-15,041
0
0
0
-16,576
-16,576
0
0
-6,911
0
-6,911
0
-7,418
-7,418
0
0
-2,353
-2,353
0
0
-1,716
-1,716
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000-1,716-1,71600-2,353-2,35300-7,418-7,4180-6,9110-6,91100-16,576-16,576000-15,041-42,349-43,330-43,848-14,220-14,4510-148,283200000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
164,974
172,613
174,635
179,148
180,896
191,443
191,566
210,660
210,744
214,609
221,657
222,513
225,432
225,491
225,733
226,041
229,971
237,574
237,467
237,462
237,462
238,062
239,090
239,256
243,999
255,939
266,665
266,666
267,091
267,171
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000267,171267,091266,666266,665255,939243,999239,256239,090238,062237,462237,462237,467237,574229,971226,041225,733225,491225,432222,513221,657214,609210,744210,660191,566191,443180,896179,148174,635172,613164,9740000000000
   Treasury Stock00000000000000000000000000000000000000-12000000000000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.